FIELD: medicine, neurology, pharmacy. SUBSTANCE: invention relates to methods and pharmaceutical compositions used for stimulation of growth of neuritis in nerve cells containing neurotrophic amount of compound that binds with FK-506-binding protein (FKBP) and neurotrophic factor, for example, nerve growth factor. Compositions accelerate healing neuronal damage caused by sickness or physical trauma. EFFECT: enhanced effectiveness of stimulation, valuable medicinal properties. 41 cl, 2 dwg, 8 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF AMINO ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF SUPPRESSION OF MULTIDRUG RESISTANCE | 1995 |
|
RU2165410C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING LACTIC ACID BUTYRATE PRODRUG | 1996 |
|
RU2175967C2 |
| DERIVATIVES OF 1-(2-OXOACETYL)-PIPERIDINE- OR PYRROLIDINE-2-CARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT, METHOD OF SYNTHESIS | 1993 |
|
RU2158258C2 |
| METHOD OF PRODUCING BIARYLUREA AND ANALOGUES THEREOF | 2006 |
|
RU2431630C2 |
| METHOD FOR TREATING GLUTAMATE DISORDERS | 1997 |
|
RU2211697C2 |
| CASPASE INHIBITOR PRODRUGS | 2006 |
|
RU2427582C2 |
| 6-AMINO-MORPHINANE DERIVATIVES AND USES THEREOF | 2002 |
|
RU2306314C2 |
| PYRROLOPYRAZINES SUITABLE AS AURORA A KINASE INHIBITORS | 2005 |
|
RU2394825C2 |
| CASPASE INHIBITORS AND USE THEREOF | 2004 |
|
RU2372335C2 |
| DERIVATIVES OF 3-[2-(3-ACYLAMINO-2-OXO-2H-PYRIDIN-1-YL)-ACETYLAMINO]-4-OXO-PENTANE ACID AND THEIR APPLICATION AS CASPASE INHIBITORS | 2005 |
|
RU2412936C2 |
